Ryan Swenerton

Title: Innovations in Cancer Detection by Ryan Swenerton

Introduction

Ryan Swenerton is an accomplished inventor based in San Bruno, California. He has made significant contributions to the field of cancer detection and monitoring, holding a total of nine patents. His work focuses on developing advanced methods for identifying and tracking cancerous conditions, particularly in breast, bladder, and colorectal cancers.

Latest Patents

Among his latest patents, Swenerton has developed methods for cancer detection and monitoring. This invention provides techniques for detecting single nucleotide variants in various cancers. It includes methods for monitoring early relapse or metastasis of these cancers by generating a set of amplicons through multiplex amplification reactions on nucleic acids isolated from blood or urine samples. The detection of patient-specific single nucleotide variants is crucial for indicating potential cancer relapse. Additionally, he has created methods for detecting immune cell DNA and monitoring immune system health. These methods are particularly beneficial for patients undergoing treatments that deplete immune cells, utilizing multiplex PCR combined with next-generation DNA sequencing to identify immune cell populations.

Career Highlights

Ryan Swenerton is currently employed at Natera, Inc., a company known for its innovative approaches in genetic testing and diagnostics. His work at Natera has allowed him to focus on developing cutting-edge technologies that enhance cancer detection and patient monitoring.

Collaborations

Swenerton collaborates with notable colleagues, including Bernhard Zimmermann and Himanshu Sethi. Their combined expertise contributes to the advancement of methodologies in cancer research and diagnostics.

Conclusion

Ryan Swenerton's innovative work in cancer detection and monitoring exemplifies the impact of scientific research on healthcare. His patents reflect a commitment to improving patient outcomes through advanced diagnostic techniques.